🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

CRI Clinical Innovator Dr. Marina Baretti of Johns Hopkins Medicine presents, "Exploiting A Critical Vulnerability to Glutamine Antimetabolite Therapy in Fibrolamellar Hepatocellular Carcinoma (FLC)," on the third day of #CICON24. #CancerResearch

📢Join us on September 28 for the Multidisciplinary Management of #HCC! Join in-person or virtually. For conference details and to register, visit hopkinscme.cloud-cme.com/course/courseo… Mark Yarchoan Jin He Johns Hopkins Medicine Johns Hopkins University

Marina Baretti discussing locoregional therapies for patients with intrahepatic #CCA at #ILCA24 ILCA

What a start for #ILCA24 ! Enthusiastic participation to the roundtables organised by the Young ILCA committee - so enlightening to hear the career development advice of our stellar speakers! Marina Baretti Grainne O'Kane chiara braconi Valerie Chew ILCA

Glad to be part of #ILCA24 with friends, colleagues, and mentees (not mutually exclusive 😊)! David James Pinato 🇺🇦 Marina Baretti Antonio D'Alessio Angelo Pirozzi ILCA Humanitas University Humanitas Milano

Just out on the The Lancet Oncology : our NeoHCC Study 🗞️ 📈 Path response after neoadj ICI predicts for RFS in HCC 🔥 HR 0.26 for RFS improvement with MPR 📊 30% of MPR is not predicted by ORR using RECIST 1.1 🎯 90% regression is the best threshold for RFS David James Pinato 🇺🇦 ILCA

1/8 Excited to share our latest study in Nature Immunology led by @DanielShuMD on TLS in #HCC patients treated w/ neoadj ICB: ⏩ TLS linked to improved outcomes ⏩ Novel "involuted" TLS found in tumor regression zones 🔗 nature.com/articles/s4159…

🚨 Don’t miss this ! Join us Wed. Nov 13, 6:30-8pm EST for a powerful webinar on Advances in HCC/Biliary Tract Cancers. Learn from top experts on treatments, trials & patient perspectives. 👉 Register now: tinyurl.com/3zhbj54u #HCC #BiliaryCancer #HPB #HPBSurgery

Entinostat + Nivolumab Yields Durable Results in Some Pancreatic Cancer Patients. Marina Baretti HealthDay News bit.ly/4g4YWFq

Thrilled to see our study published Nature Communications

Johns Hopkins Kimmel Cancer Center Ghassan Abou-Alfa Kelly Lafaro Mark Yarchoan Rachna Shroff, MD, MS, FASCO Johns Hopkins Kimmel Cancer Center #GIOnc 👉Most #cholangiocarcinoma patients unfortunately do not have operable disease 🤔But could some tumors be rendered operable with pre-operative therapy? Marina Baretti & Dr. Keith Unger🗣️the role of systemic chemoTx +/- radiation☢️for such patients

Honored to discuss #cholangiocarcinoma 💚 Johns Hopkins Medicine GI 🦀 course w/ fellow oncs Thx 🙏🏼 Mike Pishvaian and Marina Baretti for 📨 Rachna Shroff, MD, MS, FASCO Melinda Bachini Cholangiocarcinoma Foundation OHSU Knight Cancer Institute #oncologistswhocanoperate

🚨 New manuscript led by Marina Baretti, Cholangiocarcinoma Foundation Using #CODEX multiplexed imaging: 🧬 #CCA is rich in CAFs,TAMs,MDSCs, scarce CD8 T cells (~1.8% of all cells) 🧬 FGFR2 fusions → ⬆️ CD11b+/CD15+ granulocytes 🧬 IDH1 mutations → trend ⬆️M2-like mac 🔗pubmed.ncbi.nlm.nih.gov/39969434/

In Press: Propensity Score–Weighted Analysis of Neoadjuvant Therapy Versus Upfront Surgical Resection in Patients with #BiliaryTractCancers Marina Baretti Richard Burkhart ow.ly/OSxR50VtSyv Flavio G Rocha, MD, FACS, FSSO Michael Cavnar Julie Hallet @SKMaithel Juliet S Lumati (Okoroh) MD MPH Lee M. Ocuin MD, FACS

Congratulations to all, including our very own YIA awardees Drs. Ferreira, Liang, Mo, Walsh, and Zavras AND a well deserved CDA to alum Dr. Baretti! Phaedon Zavras Kai-li Liang Michelle Ferreira Marina Baretti

#ASCO25 Delighted to serve as track chair for Developmental Therapeutics/IO 💡Highlight of our track today: Oral abstract session in Hall D2 showcasing advances in: - Bispecifcs #TimYap - Novel vaccines Marina Baretti - Toxicities Ben Creelan, MD ASCO Beaumont RCSI Cancer Centre OncoAlert

Congratulations to our 🌟 Johns Hopkins Hematology and Oncology Fellowship fellows Drs. Ferreira, Liang, Mo, Walsh and Zavras on their ASCO Conquer Cancer, the ASCO Foundation Young Investigator Awards. And to our alumna/phenomenal faculty member Marina Baretti on her CDA! So incredibly proud of their hard work & dedication 🤩🙌🏼

The future of medical oncology is brighter than ever #ASCO2025 Marina Baretti Kristen A. Marrone, MD Kai-li Liang Phaedon Zavras

I am so glad to see a study focused on #fibrolamellar carcinoma at #ASCO25 #Vaccine against DNAJ-PKAc With IpiNivo Phase I study Encouraging results 🤞🏻 ASCO Grupo Español de Tratamiento de Tumores Digestivos SEOM

Thank you ASCO for selecting our work in #FLC and helping highlight the importance of talking about #rare cancers. Awareness leads to research, and research leads to hope Mark Yarchoan Fibrolamellar Cancer